GI Dynamics is a little-known Massachusetts company with a novel non-surgical endoscopic therapy that causes weight loss. I discovered GI Dynamics (OTC:GIDYL) while traveling in Australia in 2011. It's a company new to Seeking Alpha readers and to most investors, and may hold promise for considerable share price appreciation for its "diabesity" treatment called EndoBarrier.
GI Dynamics was founded in 2003 and, for somewhat arcane reasons, originally sought capital via a 2011 IPO in Australia, seemingly on the basis that EndoBarrier would be approved sooner there than in the US, where it is still investigational. EndoBarrier is now approved and in use in Australia, Austria, Chile, Germany, Israel, Italy, Netherlands, and the United Kingdom. GIDYL began trading on...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|